Hepatic microcirculation in ischemia/reperfusion: Is there a role for poly(adenosine 5′-diphosphate-ribose) polymerases?

Critical Care Medicine

Volumn 32, Issue 2, 2004, Pages 605-607

  Mariscalco, M Michele ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

DNA strand breaks; Hemorrhagic shock; Poly(adenosine 5 diphosphate ribose) polymerase; Poly(adenosine 5 diphosphate ribose) synthetase; enzymes; Sepsis

Indexed keywords

5 AMINOISOQUINOLONE; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; QUINOLONE DERIVATIVE; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTERIOLE; BIOACCUMULATION; CELL DEATH; CELL SURVIVAL; EDITORIAL; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; LEUKOCYTE ADHERENCE; LIPID PEROXIDATION; LIVER BLOOD FLOW; LIVER CIRCULATION; LIVER INJURY; LIVER ISCHEMIA; LIVER PERFUSION; MICROCIRCULATION; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; THROMBOCYTE ADHESION; VENULE;

ANIMALS; ISOQUINOLINES; LIVER; LIVER CIRCULATION; MICROCIRCULATION; POLY(ADP-RIBOSE) POLYMERASES; REPERFUSION INJURY;

EID: 1242275078     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000110668.05584.F7     Document Type: Editorial

References (16)

1. Ha HC, Snyder SH: Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion. Proc Natl Acad Sci U S A 1999; 96:13978-13982
2. Yu SW, Wang H, Poitras MF, et al: Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science 2002; 297:259-263
3. Virag L, Szabo C: The therapeutic potential of poly(ADP-ribose) polymerase inhibitors. Pharmacol Rev 2002; 54:375-429
4. Thiemermann C: Development of novel, water-soluble inhibitors of poly (adenosine 5′-diphosphate ribose) synthetase activity for use in shock and ischemia-reperfusion injury. Crit Care Med 2002; 30:1163-1165
5. Jagtap P, Soriano FG, Virag L, et al: Novel phenanthridinone inhibitors of poly (adenosine 5′-diphosphate-ribose) synthetase: Potent cytoprotective and antishock agents. Crit Care Med 2002; 30:1071-1082
6. Mota-Filipe H, Sepodes B, McDonald MC, et al: The novel PARP inhibitor 5-aminoisoquinolinone reduces the liver injury caused by ischemia and reperfusion in the rat. Med Sci Monit 2002; 8:BR444-BR453
7. Khandoga A, Biberthaler P, Enders G, et al: 5-Aminoisoquinolinone, a novel inhibitor of poly(adenosine disphosphate-ribose) polymerase, reduces microvascular liver injury but not mortality rate after hepatic ischemia-reperfusion. Crit Care Med 2004; 32:472-477
8. Teoh NC, Farrell GC: Hepatic ischemia reperfusion injury: Pathogenic mechanisms and basis for hepatoprotection. J Gastroenterol Hepatol 2003; 18:891-902
9. McCuskey RS: Morphological mechanisms for regulating blood flow through hepatic sinusoids. Liver 2000; 20:3-7
10. Gujral JS, Bucci TJ, Farhood A, et al: Mechanism of cell death during warm hepatic ischemia-reperfusion in rats: Apoptosis or necrosis? Hepatology 2001; 33:397-405
11. Chosay JG, Essani NA, Dunn CJ, et al: Neutrophil margination and extravasation in sinusoids and venules of liver during endotoxin-induced injury. Am J Physiol 1997; 272: G1195-G1200
12. Essani NA, Fisher MA, Simmons CA, et al: Increased P-selectin gene expression in the liver vasculature and its role in the pathophysiology of neutrophil-induced liver injury in murine endotoxins shock. J Leukoc Biol 1998; 63:288-296
13. Uhlmann S, Uhlmann D, Spiegel HU: Evaluation of hepatic microcirculation by in vivo microscopy. J Invest Surg 1999; 12:179-193
14. Khandoga A, Biberthaler P, Enders G, et al: P-selectin mediates platelet-endothelial cell interactions and reperfusion injury in the mouse liver in vivo. Shock 2002; 18:529-535
15. Frenette PS, Denis CV, Weiss L, et al: P-Selectin glycoprotein ligand 1 (PSGL-1) is expressed on platelets and can mediate platelet-endothelial interactions in vivo. J Exp Med 2000; 191:1413-1422
16. Falati S, Liu Q, Gross P, et al: Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin. J Exp Med 2003; 197:1585-1598